General
Preferred name
HYDROXYAMPHETAMINE
Synonyms
HYDROXYAMPHETAMINE HYDROBROMIDE ()
Paredrine ()
Hydroxyamphetamine,(+/-) ()
hydroxyamfetamine ()
Hydroxyamfetamine hydrobromide ()
Oxamphetamine Hydrobromide ()
Phenol, 4-(2-aminopropyl)-, hbr ()
Hydroxyamphetamine hbr ()
NSC-61065 ()
Hydroxyamfetamine hbr ()
Hyroxyamfetamine hydrobromide ()
Racemic p-hydroxyamphetamine ()
Dl-4-hydroxyamphetamine ()
Phenol, p-(2-aminopropyl)- ()
NSC-170995 ()
Pulsoton ()
Hidroxianfetamina ()
Norveritol ()
Dl-p-hydroxyamphetamine ()
P-hydroxyamphetamine ()
4-hydroxy Amphetamine (hydrochloride) ()
P&D ID
PD014502
CAS
306-21-8
1518-86-1
140-36-3
6078-07-5
103-86-6
876-26-6
Tags
available
drug
Approved by
FDA
First approval
1969
Drug indication
Adrenergic (ophthalmic)
Horner syndrome
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
15
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Ki Database
NCATS Inxight Approved Drugs
NPC Screening Collection
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
62
Properties
(calculated by RDKit )
Molecular Weight
151.1
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
1.28
TPSA
46.25
Fraction CSP3
0.33
Chiral centers
1.0
Largest ring
6.0
QED
0.67
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data